MYLAN-LANSOPRAZOLE
MYLAN-LANSOPRAZOLE
Approved
DIN Number
02353830
Drug Class
Human
Market Date
Jun 18, 2010
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02353830
AIG Number0127666002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC03 LANSOPRAZOLE
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification
ACTIVE INGREDIENTS (1)
LANSOPRAZOLEActive
Strength: 15 MG
Monograph: LANSOPRAZOLE